 This statistic describes the top pharmaceutical chemotherapy and targeted cancer products in the United States based on revenues during 2016. Novartis' Gleevec was among the top 10 cancer products in the United States, generating some 1.2 billion U.S. dollars in revenue. Cancer risk can increase due to internal or external factors, however, many types of cancers are preventable with a healthy diet, no smoking, and physical activity. 